HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pregnancy and mechanical heart valves replacement; dilemma of anticoagulation.

AbstractOBJECTIVES:
To establish a uniform anticoagulation regimen for pregnant patients with mechanical heart valves taking into account the socio-economic background and to evaluate the incidence of anticoagulant related complications.
METHODS:
A retrospective study on 63 pregnancies in 21 women with mechanical heart valves was evaluated. These pregnancies were divided into two groups: Group I (n=42) received oral anticoagulants throughout pregnancy and Group II (n=21) received subcutaneous heparin in the 1st trimester and oral anticoagulants for the rest of pregnancy period. Both groups received heparin at time of delivery.
RESULTS:
There was no case of coumarin embryopathy seen and there was no maternal death. Life threatening valve thrombosis occurred in two patients who were both from Group II and needed emergency re-replacement. Group I had a higher incidence of spontaneous abortion than Group II although this was not statistically significant.
CONCLUSIONS:
The role of coumarin embryopathy has been overstated. We recommend the use of oral anticoagulants throughout pregnancy especially in countries with similar socio-economic background.
AuthorsAdil A M Al-Lawati, M Venkitraman, Taha Al-Delaime, John Valliathu
JournalEuropean journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery (Eur J Cardiothorac Surg) Vol. 22 Issue 2 Pg. 223-7 (Aug 2002) ISSN: 1010-7940 [Print] Germany
PMID12142189 (Publication Type: Journal Article)
Chemical References
  • Anticoagulants
  • Coumarins
  • Heparin
  • coumarin
Topics
  • Administration, Oral
  • Adult
  • Anticoagulants (administration & dosage)
  • Coumarins (administration & dosage)
  • Drug Administration Schedule
  • Female
  • Heart Valve Prosthesis
  • Heparin (administration & dosage)
  • Humans
  • Injections, Subcutaneous
  • Pregnancy
  • Pregnancy Complications, Cardiovascular (drug therapy)
  • Pregnancy Outcome
  • Retrospective Studies
  • Risk Factors
  • Thrombosis (epidemiology, prevention & control)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: